Staining for EMT markers revealed a decrease in E-cadherin especially in areas adjacent to necrotic regions and increase in ZEB1 and vimentin compared with control tumor (Fig. 7, control and sunitinib treated). This evidence concerns the gene VIM and neoplasm.